JP2021535159A5 - - Google Patents
Info
- Publication number
- JP2021535159A5 JP2021535159A5 JP2021510960A JP2021510960A JP2021535159A5 JP 2021535159 A5 JP2021535159 A5 JP 2021535159A5 JP 2021510960 A JP2021510960 A JP 2021510960A JP 2021510960 A JP2021510960 A JP 2021510960A JP 2021535159 A5 JP2021535159 A5 JP 2021535159A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkyl
- group
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024192796A JP2025016676A (ja) | 2018-08-27 | 2024-11-01 | スパイン形成のためのファシン結合化合物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862723381P | 2018-08-27 | 2018-08-27 | |
| US62/723,381 | 2018-08-27 | ||
| US201862726904P | 2018-09-04 | 2018-09-04 | |
| US62/726,904 | 2018-09-04 | ||
| US201862785435P | 2018-12-27 | 2018-12-27 | |
| US62/785,435 | 2018-12-27 | ||
| PCT/US2019/048408 WO2020046991A1 (en) | 2018-08-27 | 2019-08-27 | Fascin binding compounds for spinogenesis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024192796A Division JP2025016676A (ja) | 2018-08-27 | 2024-11-01 | スパイン形成のためのファシン結合化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535159A JP2021535159A (ja) | 2021-12-16 |
| JP2021535159A5 true JP2021535159A5 (enExample) | 2022-08-25 |
| JP7583710B2 JP7583710B2 (ja) | 2024-11-14 |
Family
ID=69644570
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510960A Active JP7583710B2 (ja) | 2018-08-27 | 2019-08-27 | スパイン形成のためのファシン結合化合物 |
| JP2024192796A Pending JP2025016676A (ja) | 2018-08-27 | 2024-11-01 | スパイン形成のためのファシン結合化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024192796A Pending JP2025016676A (ja) | 2018-08-27 | 2024-11-01 | スパイン形成のためのファシン結合化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20210330646A1 (enExample) |
| EP (1) | EP3843846A4 (enExample) |
| JP (2) | JP7583710B2 (enExample) |
| CN (1) | CN112912141B (enExample) |
| AU (1) | AU2019329835B2 (enExample) |
| CA (1) | CA3110877A1 (enExample) |
| WO (1) | WO2020046991A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3071525A1 (en) | 2017-08-02 | 2019-02-07 | Spinogenix, Inc. | Benzothiazole and related compounds |
| ES3032326T3 (en) | 2019-01-31 | 2025-07-17 | Spinogenix Inc | Solid forms of a promoter of spinogenesis |
| EP4178955A1 (en) | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| JP2024507224A (ja) * | 2021-02-22 | 2024-02-16 | スピノジェニックス， インコーポレイテッド | 脊髄傷害または損傷を処置する方法 |
| US20240180920A1 (en) * | 2021-03-23 | 2024-06-06 | Spinogenix, Inc. | Certain fascin binding compounds for spinogenesis |
| AU2024244089A1 (en) * | 2023-04-03 | 2025-10-30 | Spinogenix, Inc. | Methods of dosing spinogenic compounds |
| CN121773104A (zh) * | 2023-06-30 | 2026-03-31 | 北京双鹤润创科技有限公司 | 肌成束蛋白抑制剂 |
| WO2025184576A1 (en) * | 2024-02-29 | 2025-09-04 | Spinogenix, Inc. | Methods for prevention and treatment of depression |
| WO2026050308A1 (en) * | 2024-08-26 | 2026-03-05 | Spinogenix, Inc. | Benzothiazole compound for treating or preventing diabetes |
| WO2026050303A1 (en) * | 2024-08-26 | 2026-03-05 | Spinogenix, Inc. | Methods of treating ophthalmic diseases |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| AU2012239977B9 (en) | 2011-04-07 | 2016-11-17 | Sloan-Kettering Institute For Cancer Research | Migrastatins and uses thereof |
| WO2013013240A2 (en) * | 2011-07-21 | 2013-01-24 | Theracrine, Inc. | Macrocyclic compounds and related compositons and methods of use |
| CN103889983B (zh) * | 2011-09-14 | 2015-12-09 | 普罗克西梅根有限公司 | 酶抑制剂化合物 |
| CA3139033A1 (en) | 2012-08-22 | 2014-02-27 | Cornell University | Methods for inhibiting fascin |
| WO2015127125A1 (en) * | 2014-02-20 | 2015-08-27 | Cornell University | Compounds and methods for inhibiting fascin |
| CA3010445A1 (en) * | 2016-01-05 | 2017-07-13 | The Regents Of The University Of California | Benzothiazole amphiphiles |
| TWI586367B (zh) | 2016-03-28 | 2017-06-11 | 蔡懷楨 | 磷酸甘油酯激酶增加神經突生長及／或治療神經性疾病的用途 |
| CA3071525A1 (en) * | 2017-08-02 | 2019-02-07 | Spinogenix, Inc. | Benzothiazole and related compounds |
-
2019
- 2019-08-27 EP EP19854074.2A patent/EP3843846A4/en active Pending
- 2019-08-27 WO PCT/US2019/048408 patent/WO2020046991A1/en not_active Ceased
- 2019-08-27 CA CA3110877A patent/CA3110877A1/en active Pending
- 2019-08-27 AU AU2019329835A patent/AU2019329835B2/en active Active
- 2019-08-27 CN CN201980070624.1A patent/CN112912141B/zh active Active
- 2019-08-27 US US17/271,163 patent/US20210330646A1/en not_active Abandoned
- 2019-08-27 JP JP2021510960A patent/JP7583710B2/ja active Active
-
2024
- 2024-04-08 US US18/629,627 patent/US20240423962A1/en active Pending
- 2024-11-01 JP JP2024192796A patent/JP2025016676A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535104A5 (enExample) | ||
| JP2023514872A5 (enExample) | ||
| JP2022545359A5 (enExample) | ||
| JP2013535460A5 (enExample) | ||
| JP2023545396A5 (enExample) | ||
| JP2009536620A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| JP2014521653A5 (enExample) | ||
| JP2011509309A5 (enExample) | ||
| JP2007502804A5 (enExample) | ||
| JP2017502993A5 (enExample) | ||
| JP2004537564A5 (enExample) | ||
| JP2004511466A5 (enExample) | ||
| JP2011515482A5 (enExample) | ||
| RU2013108702A (ru) | Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине | |
| JP2017502994A5 (enExample) | ||
| JP2017526677A5 (enExample) | ||
| JP2012503018A5 (enExample) | ||
| RU2006128426A (ru) | Производные тиофенав в качестве ингибиторов снк 1 | |
| JP2019508496A5 (enExample) | ||
| JP2021511359A5 (enExample) | ||
| JP2021535134A5 (enExample) | ||
| JP2011517697A5 (enExample) | ||
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| JP2013508452A5 (enExample) |